Matthias G. J. Baud

1.5k total citations · 1 hit paper
26 papers, 1.1k citations indexed

About

Matthias G. J. Baud is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Matthias G. J. Baud has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Matthias G. J. Baud's work include Protein Degradation and Inhibitors (8 papers), Histone Deacetylase Inhibitors Research (6 papers) and Click Chemistry and Applications (5 papers). Matthias G. J. Baud is often cited by papers focused on Protein Degradation and Inhibitors (8 papers), Histone Deacetylase Inhibitors Research (6 papers) and Click Chemistry and Applications (5 papers). Matthias G. J. Baud collaborates with scholars based in United Kingdom, Germany and Russia. Matthias G. J. Baud's co-authors include Charlene Fallan, Matthew J. Fuchter, Franz‐Josef Meyer‐Almes, Alessio Ciulli, Andreas C. Joerger, Claire E. Weston, Alan R. Fersht, Michael Zengerle, Matthias R. Bauer and Enrique Lin-Shiao and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Analytical Biochemistry.

In The Last Decade

Matthias G. J. Baud

26 papers receiving 1.1k citations

Hit Papers

Current strategies for the design of PROTAC linkers: a cr... 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Current strategies for the design of PROTAC linkers: a critical review
    2020 248 citations Matthias G. J. Baud et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias G. J. Baud United Kingdom 19 790 306 267 179 160 26 1.1k
Philipp Holzer Switzerland 16 701 0.9× 318 1.0× 483 1.8× 124 0.7× 54 0.3× 27 1.2k
K. Ulrich Wendt Germany 18 662 0.8× 246 0.8× 167 0.6× 100 0.6× 98 0.6× 29 1.0k
Takuji Shoda Japan 17 828 1.0× 233 0.8× 158 0.6× 201 1.1× 132 0.8× 35 1.3k
Kurt W. Vogel United States 17 628 0.8× 168 0.5× 115 0.4× 94 0.5× 44 0.3× 36 909
Kamil Paruch Czechia 22 891 1.1× 611 2.0× 507 1.9× 148 0.8× 55 0.3× 52 1.7k
Daniel Abegg United States 26 1.4k 1.7× 202 0.7× 547 2.0× 104 0.6× 41 0.3× 55 1.9k
Pier F. Cirillo United States 16 1.0k 1.3× 260 0.8× 777 2.9× 121 0.7× 92 0.6× 30 1.7k
Swen Hoelder United Kingdom 16 1.1k 1.4× 246 0.8× 390 1.5× 85 0.5× 226 1.4× 22 1.5k
Bainan Wu United States 22 880 1.1× 244 0.8× 150 0.6× 80 0.4× 31 0.2× 28 1.2k
Jack Sadowsky United States 21 1.3k 1.7× 384 1.3× 642 2.4× 69 0.4× 45 0.3× 32 1.7k

Countries citing papers authored by Matthias G. J. Baud

Since Specialization
Citations

This map shows the geographic impact of Matthias G. J. Baud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias G. J. Baud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias G. J. Baud more than expected).

Fields of papers citing papers by Matthias G. J. Baud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias G. J. Baud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias G. J. Baud. The network helps show where Matthias G. J. Baud may publish in the future.

Co-authorship network of co-authors of Matthias G. J. Baud

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias G. J. Baud. A scholar is included among the top collaborators of Matthias G. J. Baud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias G. J. Baud. Matthias G. J. Baud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baud, Matthias G. J., et al.. (2025). Cysteine sulfinic acid and sulfinylated peptides. RSC Chemical Biology. 6(7). 1019–1033. 1 indexed citations
2.
Valle‐Argos, Beatriz, Thomas E. Wales, R Joseph, et al.. (2024). Exploring 2-Sulfonylpyrimidine Warheads as Acrylamide Surrogates for Targeted Covalent Inhibition: A BTK Story. Journal of Medicinal Chemistry. 67(16). 13572–13593. 2 indexed citations
3.
Jones, Megan, Michael McCoy, Andreas C. Joerger, et al.. (2023). Structure–Reactivity Studies of 2-Sulfonylpyrimidines Allow Selective Protein Arylation. Bioconjugate Chemistry. 34(9). 1679–1687. 11 indexed citations
4.
Douglas, Leon, et al.. (2022). Discovery of Nanomolar-Affinity Pharmacological Chaperones Stabilizing the Oncogenic p53 Mutant Y220C. ACS Pharmacology & Translational Science. 5(11). 1169–1180. 33 indexed citations
5.
Wells, Neil J., et al.. (2022). Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale. Journal of Medicinal Chemistry. 65(10). 7246–7261. 21 indexed citations
6.
Zmievskaya, Ekaterina, et al.. (2020). Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy. Frontiers in Oncology. 10. 1460–1460. 30 indexed citations
7.
Baud, Matthias G. J., Matthias R. Bauer, Lorena Verduci, et al.. (2018). Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines. European Journal of Medicinal Chemistry. 152. 101–114. 64 indexed citations
8.
Felix, Robert, et al.. (2017). Gram-Scale Laboratory Synthesis of TC AC 28, a High-Affinity BET Bromodomain Ligand. ACS Omega. 2(8). 4328–4332. 4 indexed citations
9.
Bauer, Matthias R., Matthias G. J. Baud, Rainer Wilcken, et al.. (2016). Harnessing Fluorine–Sulfur Contacts and Multipolar Interactions for the Design of p53 Mutant Y220C Rescue Drugs. ACS Chemical Biology. 11(8). 2265–2274. 55 indexed citations
10.
Baud, Matthias G. J., Enrique Lin-Shiao, Michael Zengerle, C. Tallant, & Alessio Ciulli. (2015). New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition. Journal of Medicinal Chemistry. 59(4). 1492–1500. 38 indexed citations
11.
Joerger, Andreas C., Matthias R. Bauer, Rainer Wilcken, et al.. (2015). Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant p53. Structure. 23(12). 2246–2255. 49 indexed citations
12.
Richardson, Robert D., Matthias G. J. Baud, Claire E. Weston, et al.. (2015). Dual wavelength asymmetric photochemical synthesis with circularly polarized light. Chemical Science. 6(7). 3853–3862. 75 indexed citations
13.
Baud, Matthias G. J., Enrique Lin-Shiao, Teresa A.F. Cardote, et al.. (2014). A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes. Science. 346(6209). 638–641. 110 indexed citations
14.
Meyners, Christian, Matthias G. J. Baud, Matthew J. Fuchter, & Franz‐Josef Meyer‐Almes. (2014). Kinetic method for the large-scale analysis of the binding mechanism of histone deacetylase inhibitors. Analytical Biochemistry. 460. 39–46. 18 indexed citations
15.
Baud, Matthias G. J., Vanessa Petrucci, Mekala Gunaratnam, et al.. (2013). Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors. Beilstein Journal of Organic Chemistry. 9. 81–88. 24 indexed citations
16.
Dias, David M., Inge Van Molle, Matthias G. J. Baud, et al.. (2013). Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein–Protein Interactions?. ACS Medicinal Chemistry Letters. 5(1). 23–28. 43 indexed citations
17.
18.
Baud, Matthias G. J., et al.. (2010). New synthetic strategies towards psammaplin A, access to natural product analogues for biological evaluation. Organic & Biomolecular Chemistry. 9(3). 659–662. 26 indexed citations
19.
Baud, Matthias G. J., Claudia Bello, Maria Giovanna Dal Bello, et al.. (2009). Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 20(17). 5353–5356. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philipp Holzer Breakdown of academic impact, for papers by K. Ulrich Wendt Breakdown of academic impact, for papers by Takuji Shoda Breakdown of academic impact, for papers by Kurt W. Vogel Breakdown of academic impact, for papers by Kamil Paruch Breakdown of academic impact, for papers by Daniel Abegg Breakdown of academic impact, for papers by Pier F. Cirillo Breakdown of academic impact, for papers by Swen Hoelder Breakdown of academic impact, for papers by Bainan Wu Breakdown of academic impact, for papers by Jack Sadowsky
Rankless by CCL
2026